China Pioneer Pharma Holdings Limited reported unaudited consolidated cash flow results for the six months ended June 30, 2017. For the six months, the company reported net cash flow from operating activities of RMB 132,250,000 compared to RMB 113,163,000 a year ago. Purchases of property, plant and equipment was RMB 58,000 compared to RMB 1,656,000 a year ago. Payment for intangible assets was RMB 230,000 compared to RMB 1,998,000 a year ago.